Subjects: RESEARCH; SEROPREVALENCE; IMMUNOGLOBULINSIRAN
Record details
Subjects: PUBLIC health surveillance; VIRAL antibodies; HUMAN services programsSPAIN
Subjects: IMMUNOGLOBULINS; SEROPREVALENCE; SARS-CoV-2
Subjects: SEROPREVALENCE; SARS-CoV-2; ANTIBODY formationMALI; BAMAKO (Mali)JOHNSON & Johnson (Company)
Subjects: FERAL dogs; LEISHMANIA infantum; PROTOZOAN diseasesBULGARIA; SOFIA (Bulgaria)
Subjects: COVID-19 vaccines; SARS-CoV-2; SEROPREVALENCE